High Court Won’t Hear InFuse Off-Label Preemption Case
This article was originally published in The Gray Sheet
The case would have tested whether manufacturers could be held liable if an FDA-approved device injured a patient when the product was employed for an off-label, unapproved use. The Oklahoma Federal Court and the 10th Circuit Court of Appeals had both previously ruled in industry’s favor.
Register for our free email digests: